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and NTD90, rep.). NTD parameter was evaluated in a virtual structure 
consisting of an adjacent tissue shell surrounding the target volume by 
adding a 1 cm margin. A two tailed Student t-test (α= 0.05) was 
performed for comparison of each parameter. 
Results: Small differences were found between the two MLCs for the 
average values of the dosimetric parameters analysed: CISTD= 1.45 vs 
CIHD= 1.41 (p= 0.119); GSTD=5.8 mm vs GHD= 5.6 mm (p< 0.0002) ; 
V12STD=5.77 cc vs V12HD= 5.49 cc (p< 0.02); NTD50STD= 43.41 cc vs 
NTD50HD= 41.16 cc (p< 0.01); NTD70STD= 22.62 cc vs NTD50HD = 21.19 
cc (p<0.002); and NTD90STD= 9.52 cc vs NTD90HD= 8.84 cc (p< 0.02).  
Conclusions: While the 2.5 mm HD MLC gives slightly better values 
than the 5 mm MLC for all parameters analysed, the differences seem 
clinically not relevant.  
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Purpose/Objective: The use of 16-bit depth scanner images (CT) for 
dose calculation in radiotherapy allows considering the density of 
high-Z material, while12-bit depth CT saturates. The aim of this study 
is to evaluate the dosimetric impact of metallic implants considering 
12 and 16-bit CT images, for helical treatments. Pelvic, Head and 
Neck and prostheses irradiations are considered. 
Materials and Methods: Dosimetric calculations were performed 
withTomoTherapy® planning software (voLOTM). Extended CT to 
physical density curve (CT-PD) was derived from tissue 
characterization phantom with Titanium insert (7200 ± 90 HU , 4.59 
g/cc). TomoTherapy® planning software extrapolates linearly the CT-
PD curve for HU numbers above the maximum point of the curve. Ten 
patients were considered for each of the 3 localizations. For each 
patient, an extended (16-bit) and non-extended (12-bit) version of the 
same CT were reconstructed. Artifacts in soft tissues due to metallic 
implants were manually corrected. Moreover, as reference, a metal-
free CT was created for each patient by replacing metallic densities 
with bone, teeth or soft tissue densities. For helical irradiation, all 
gantry angles were allowed. Number of Monitor Unit (MU), dose 
distribution andHistogram-Dose-Volume (HDV) were compared. 
Results: For 12-bit CT, metallic implants saturates at 3071 HU (2.68 
g/cc), while for 16-bit CT, range CT numbers were [7000-16500 
HU](i.e. [4.76 – 9.51 g/cc]) and [5000-31700 HU] (i.e. [3.76 – 17.11 
g/cc]) for hip prostheses and metallic dental filling, respectively. For 
Head and Neck and pelvic helical irradiations, no significant 
differences were observed for MU and dose distribution, between 
calculation from 16-bit, 12-bit and metal-free CT. For prostheses 
irradiation, MU calculation from 12-bit depth CT and metal-free CT 
are similar, while calculation from 16-bit depth CT increased MU 
calculation more than 5%. 
Conclusions: Real physical densities of metallic implants such as 
prosthese sand dental filling are much higher than maximal density of 
12-bit depth CT images. However, for helical treatment, due to the 
important number of projections, metallic implants such as prostheses 
and dental filling have a negligible impact on dose calculation for non-
metallic targets. Therefore, avoiding metallic structures is not 
necessary allowing a better target-dose conformity and organ-at-risk 
sparing. On the contrary, for metallic irradiation, the use of non-
saturated images increases significantly MU calculation (>5%). 
However, the extrapolation of CT-PD curve and accuracy of algorithms 
in high densities medium should be investigated. Modification in 
practice for metallic targets should be considered carefully. 
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Purpose/Objective: In 2008 Papiez and Timmerman have written: 
'The main obstacle for safe application of the SBRT (...) is the 
unavailability of data that allow unambiguous determination of the 
parameters for fractionation schemes and dose prescriptions.' Plan 
comparison is difficult with various prescriptions (80% of maximum 
dose, on the 70% or 50%), a large variety of indexes are used 
(conformity, gradient …). Furthermore in clinical studies, only one 
dose is reported most of the times which does not permit to precisely 
describe the dose distribution. In 2010 the report of AAPM TG 101 
suggests to report SBRT with 'prescription ICRU reference point or 
dose/volume e.g., isodose covering PTV to a particular 
percentage,(…), plan conformity (…), heterogeneity index (…)'. At the 
same time ICRU report 83 for IMRT was published, because of inherent 
heterogeneities of IMRT plans the ICRU point is abandoned and 
prescription is based on median target dose. Can we conciliate these 2 
reports? 
Materials and Methods: Theoretical plans with Cyberknife, in 
anthropomorphic phantom, for spherical GTV of 2, 3, 4 and 5 mm with 
a PTV margin of 1 mm were created with prescription of 10 Gy on 
74%, 65%, 54% and 47% of maximum dose respectively, perfectly 
adjusted to cover 95% of PTV. GTV median doses were collected. 
Plans with a shift equal to the PTV margin, in the direction of the 
minimum observed in the dose distribution, were created and the GTV 
median doses were again collected. The same exercise was made with 
GTV of 21, 23, 25, 27 mm and a PTV margin of 2 mm. And again with 
GTV of 57, 59, 61, 63 mm and a PTV margin of 3 mm. 3 different 
clinical situations: brain metastases, prostate and lung lesion were 
assessed with different percentage of maximum dose used for 
prescription and again applying a shift. 
Results: The GTV median dose is little sensitive to the minimum in the 
PTV, and thus remains almost constant with the shift of the isocenter 
in all cases i.e. when we imagine a systematic error equal to the PTV 
margin. With the 6 mm PTV and a prescription isodose of 54%, i.e. 
with a fall-off of 20%/mm at the edge of the PTV, the GTV median 
dose is 14.77 Gy and 14.75 Gy with the shift. For the particular case 
of lung where the PTV includes a low density region, using Monte-
Carlo calculation, the GTV median dose is also stable with the shift. In 
case of a steep dose gradient, even with heterogeneity, the GTV 
median dose is stable when the GTV moves within the PTV. Using the 
GTV median dose we have a good description of the actually dose 
delivered.  
Theoretical plans with a PTV margin of 2 mm  
PTV diameter (mm)  31 29 27 25 
GTV diameter (mm)  27 25 23 21 
prescription isodose in % of max
PTV D95% = 10 Gy  49% 59% 71% 81% 
GTV median dose (Gy)  17,9 15,4 13,2 11,7 
GTV median dose (Gy) with a shift  17,9 15,4 13,3 11,7 
differences  0,0% 0,0% 0,1% 0,0% 
  
Conclusions: The GTV D50% appears to be a convenient way to 
describe the dose distributions, whatever the % of maximum dose 
used for prescription, and may help for treatment comparison in 
SBRT. For a better understanding of the dose distributions, every 
team should report PTV D98%, PTV D95%, PTV D2% and GTV median 
dose like ICRU report 83 recommends for IMRT, in order to compare 
clinical studies. 
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Purpose/Objective: The atlas-based automatic segmentation can 
significantly reduce contouring time. A multi-atlas method has been 
shown to provide greater accuracy than a single best matched (SBM) 
method. In this work, we evaluated the multi-atlas based 
segmentation using majority voting approach for head and neck (H&N) 
and prostate cancer. 
Materials and Methods: 50 prostate atlases and 20 H&N atlases were 
developed and utilized for atlas-based segmentation. Prostate atlas 
contained CT images and manually defined contours of the prostate, 
seminal vesicles, rectum and bladder. H&N atlas contained CT images 
and manually defined contours of the brain stem, spinal cord, 
parotids, constrictor muscle, larynx, oral cavity and thyroid. SBM used 
one automatically selected best match atlas. Multi-atlas used multiple 
automatically selected best matches (3, 4, 5, and 10, respectively). 
And, the final segmentation fused the individual segmentations using 
majority vote rule. We performed automatic segmentation using SBM 
and multi-atlas for 10 prostate subjects and 10 H&N subjects. Average 
dice coefficients were calculated for each structure to compare 
against manually defined contours for subjects. 
Results: In prostate case, average dice coefficients of multi-atlas (3, 
4, 5, and 10) and SBM were 0.686 ± 0.192, 0.693 ± 0.192, 0.716 ± 
0.208, 0.768 ± 0.141 and 0.650 ± 0.182, respectively. There was a 
statistically significant difference between SBM and multi-atlas: 10 (P 
= 0.0014). In H&N case, average dice coefficients of multi-atlas (3, 4, 
5, and 10) and SBM were 0.709 ± 0.176, 0.737 ± 0.159, 0.740 ± 0.157, 
0.757 ± 0.132 and 0.715 ± 0.166, respectively. There was a 
statistically significant difference between SBM and multi-atlas: 10 (P 
= 0.0062). 
Conclusions: The multi-atlas based segmentation using majority 
voting was greater accuracy than SBM for H&N and prostate cancer. 
The multi-atlas based segmentation was more accurate with 
increasing the number of fused atlas. 
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Purpose/Objective: To compare the TomoTherapy® System's 
TomoDirect™ modality to the standard 3DRT technique for the 
postoperative breast radiotherapy. 
Materials and Methods: We compared the treatment plans of 30 
patients consecutively treated from February to May 2012 with the 
new TomoTherapy® System's TomoDirect™ (TD) modality for 
postoperative breast radiotherapy. The TomoDirect™ was 
implemented in our Institute from January 2012. Clinical target 
volumes (CTV) and organs at risk (OAR) were contoured for all the 
patients by the same physician to avoid interobserver variability; a 
PTV was generated by adding a 5 mm uniform margin to the CTV. 
Patients underwent the whole breast irradiation and a simultaneous 
integrated boost to the tumor bed region. The prescribed doses (at 
the 95% isodose) were 2.25-2.50 Gy/fraction up to a total dose of 45-
50 Gy (20 fractions) to the whole breast and to the postsurgical area 
respectively. Plans for TD and 3DRT were both optimized, according 
to our Intitutional protocol, in terms of dose coverage to target and 
constraints. The constraints routinely used refer to a dose of 
2Gy/fraction andare: PTV(breast), V95%≥95%, D50%£108%, 
V100%(boost dose)£30%, Dmax£115%; PTV(boost), V95%≥95%, 
Dmax<115%; Heart (right breast),Dmax<16-20Gy,V8Gy<10-15%; Heart 
(left breast), D5%<16-20Gy,V8Gy<30-35%;Heart (right/left breast) 
Dmean<3.2-4Gy; Ipsilateral lung V16Gy<15-20%,V8Gy<35-40%, 
V4Gy<50%, Controlateral lung V4Gy<10-15%;Controlateral breast 
Dmax<2.4-2.6Gy. 
Results: The dosimetric comparison related to the PTVs and to the 
OARs DVHs are reported in the Table as mean values (%) plus/minus 
the standard deviation (%). Controlateral breast maximum dose 
resulted: 2.9±2.6Gy, 2.5±2.2Gy for 3DCRT andTD respectively, while 
Controlateral lung maximum dose is about 0 Gy in both cases. 
Concerning the treatment time and the planned monitor units, the 
firsts where378±55s and 95±15s while the monitor units were 
5199±822 and 278±13 in the in the TD and 3DRT cases respectively. 
 
 
  
Conclusions: TD was investigated as an alternative technique to the 
3D conformal one for the postoperative breast radiotherapy. DVHs 
show an improvements in PTV coverage and Heart sparing. On the 
contrary, the treatment time and the monitor units of the TD 
technique are about 4 and 18 times those of the 3DRT. The real 
advantage of the TomoDirect™ is the possibility of performing the 
image guided radiotherapy and in this case results suggest that the 
use of the TD technique is definitely favourable. 
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Purpose/Objective: To investigate the advanced radiotherapy 
treatments of cutaneous Kaposi’s sarcoma of lower extremities with 
adequate target coverage and bone high sparing with volumetric 
modulated arc therapy (VMAT, RapidArc (RA)) in comparison to 
electron beams. 
Materials and Methods: Ten patients were planned with RA and, 
alternatively, with electron beams. Patients presented superficial 
target volumes adjacent to the leg’s bones and extending from the 
knees to the base of the foot in 7out of 10. Target volume longitudinal 
length was in average 45±12cm (range 29-66 cm). Dose was prescribed 
to 30Gy in 10 fractions to mean planning target volume (PTV), and 
significant maximum dose to the bone was limited to 30Gy. Plans 
were designed for 6MV photon beams for RA and 6MeV for electrons. 
For RA two groups of plans were generated: the first, RA_1, with the 
aim of respecting planning objectives for target coverage, 
homogeneity and maximum dose to the bones, the second group, 
RA_2,was generated adding the request to maximise bone sparing 
without significant compromises to target objectives. Dose 
distributions were computed with AcurosXB for photons and with 
Monte Carlo for the electrons. 
Results: Given the specificity of the target, PTV coverage was 
acceptably for both RA_1 (V95%>95%,V107%<0.5%) and RA_2 plans 
(V90%>95% V107%<5.0%) respecting the objective of a bone sparing with 
D2%<30Gy, while, although acceptable for bone involvement, 
pronounced target coverage violations were obtained for electron 
plans. MU resulted comparable for electrons and RA although the 
latter increased when a superior bone sparing was imposed, reaching, 
however, a significant improvement also respect electrons plans on all 
the analyzed parameters for bone DVHs (D2%, D10cm3 and D20cm3, and Vx 
with x=10, 20, 30Gy, mean dose). Delivery time were 12.1±4.0 
minutes for electrons and 4.8±1.3 minutes for the most modulated RA 
plans (RA_2). 
Conclusions: High plan quality was shown for Kaposi sarcoma in the 
lower extremities using VMAT and this might simplify the management 
of these treatments in comparison to more conventional usage of 
electrons, particularly in institutes with limited staff resources and 
heavy workloads. In addition, VMAT demonstrated dosimetrically 
extremely advantageous and a flexible approach also in a typology of 
treatments where electron beam therapy is mainly considered to be 
effective due to the limited penetration of the beams.  
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